Literature DB >> 12750368

The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function.

Martin Monte1, Roberta Benetti, Giacomo Buscemi, Peter Sandy, Giannino Del Sal, Claudio Schneider.   

Abstract

GTSE-1 (G2 and S phase-expressed-1) protein is specifically expressed during S and G2 phases of the cell cycle. It is mainly localized to the microtubules and when overexpressed delays the G2 to M transition. Here we report that human GTSE-1 (hGTSE-1) protein can negatively regulate p53 transactivation function, protein levels, and p53-dependent apoptosis. We identified a physical interaction between the C-terminal regulatory domain of p53 and the C-terminal region of hGTSE-1 that is necessary and sufficient to down-regulate p53 activity. Furthermore, we provide evidence that hGTSE-1 is able to control p53 function in a cell cycle-dependent fashion. hGTSE-1 knock-down by small interfering RNA resulted in a S/G2-specific increase of p53 levels as well as cell sensitization to DNA damage-induced apoptosis during these phases of the cell cycle. Altogether, this work suggests a physiological role of hGTSE-1 in apoptosis control after DNA damage during S and G2 phases through regulation of p53 function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750368     DOI: 10.1074/jbc.M302902200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Ethyl acetate extracts of Fructus Ligustri Lucide induce cell apoptosis in human neuroglioma cell.

Authors:  Yun-Bao Guo; Yi-Meng Shao; Jing Chen; Song-Bai Xu; Xing-Dong Zhang; Hai-Yan Liu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  High resolution array-CGH characterization of human stem cells using a stem cell focused microarray.

Authors:  Aaron M Elliott; Kristi A Hohenstein Elliott; Anja Kammesheidt
Journal:  Mol Biotechnol       Date:  2010-11       Impact factor: 2.695

3.  Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.

Authors:  Renata A Canevari; Fabio A Marchi; Maria A C Domingues; Victor Piana de Andrade; José R F Caldeira; Sergio Verjovski-Almeida; Silvia R Rogatto; Eduardo M Reis
Journal:  Tumour Biol       Date:  2016-08-02

4.  p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo.

Authors:  Sydney M Moyer; Amanda R Wasylishen; Yuan Qi; Natalie Fowlkes; Xiaoping Su; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

5.  Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery.

Authors:  X Shawn Liu; Hongchang Li; Bing Song; Xiaoqi Liu
Journal:  EMBO Rep       Date:  2010-06-25       Impact factor: 8.807

Review 6.  The substrates of Plk1, beyond the functions in mitosis.

Authors:  X Shawn Liu; Bing Song; Xiaoqi Liu
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

7.  Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment.

Authors:  Débora Rosa Bublik; Massimiliano Scolz; Gianluca Triolo; Martín Monte; Claudio Schneider
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

8.  Honokiol induces cell cycle arrest and apoptosis via p53 activation in H4 human neuroglioma cells.

Authors:  Yun-Bao Guo; Xin-Jie Bao; Song-Bai Xu; Xing-Dong Zhang; Hai-Yan Liu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.

Authors:  Cheng Zhang; Li Min; Liyi Zhang; Yuanyuan Ma; Yue Yang; Chengchao Shou
Journal:  Tumour Biol       Date:  2015-09-09

10.  Chemical Regeneration of Wound Defects: Relevance to the Canine Palatal Mucosa and Cell Cycle Up-Regulation in Human Gingival Fibroblasts.

Authors:  Kyungho Lee; Heithem Ben Amara; Sang Cheon Lee; Richard Leesungbok; Min Ah Chung; Ki-Tae Koo; Suk Won Lee
Journal:  Tissue Eng Regen Med       Date:  2019-11-21       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.